Overcoming the blood—brain barrier: FDA-approved drug could aid therapeutic delivery
Researchers from Cornell University (NY, USA) have demonstrated that an existing FDA-approved drug could be utilized to deliver therapeutic agents to the brain, potentially facilitating treatment of Alzheimer’s disease and chemotherapy-resistant cancers.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>